Veru receives patent allowance for enobosarm and semaglutide combo
Go back to Veru receives patent allowance for enobosarm and semaglutide combo| (NASDAQ: VERU) | Delayed: 2.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.77 | 52 Week High | $ | |||
| Open | $2.77 | 52 Week Low | $ | |||
| Day High | $2.77 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 915 | |||||
